Innogenetics N.V.
86Patents
7Active
86Granted
36Portfolio score
Filing activity: Mar 23, 1990 → Jul 19, 2012 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6458386B1 | Medicaments based on polymers composed of methacrylamide-modified gelatin | Human Necessities | 99 | Expired |
| US6277605A | Isothermal polymerase chain reaction by cycling the concentration of divalent metal ions | Chemistry; Metallurgy | 89 | Expired |
| US6440662B1 | Impedimetric detection system and method of production thereof | Physics | 89 | Expired |
| US6132759A | Medicaments containing gelatin cross-linked with oxidized polysaccharides | Human Necessities | 75 | Expired |
| US6555114B1 | Immunodominant human T-cell epitopes of hepatitis C virus | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6350860B1 | Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders | Chemistry; Metallurgy | 35 | Expired |
| US5304466A | HIV-3 retrovirus and its use | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6858387B1 | Nucleic acid probes and methods for detecting clinically important fungal pathogens | Chemistry; Metallurgy | 25 | Expired |
| US6566103B2 | Isothermal polymerase chain reaction by cycling the concentration of divalent metal ions | Chemistry; Metallurgy | 24 | Expired |
| US6670137B2 | Differential diagnosis of neurological diseases | Physics | 21 | Expired |
| US6121003A | Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6008024A | Monoclonal antibodies specific for PHF-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications | Chemistry; Metallurgy | 19 | Expired |
| US6680173B2 | Diagnosis of tauopathies | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6548244B2 | Process for typing HCV isolates | Chemistry; Metallurgy | 17 | Expired |
| US6613333B1 | Immunodominant human T-cell epitopes of hepatitis C virus | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6150134A | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Emerging Cross-Sectional Technologies | 16 | Expired |
| US7101561B2 | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Chemistry; Metallurgy | 16 | Expired |
| US7238356B2 | Core-glycosylated HCV envelope proteins | Chemistry; Metallurgy | 14 | Expired |
| US6500674B1 | Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications | Chemistry; Metallurgy | 14 | Expired |
| US6204359A | Form of amphiregulin, methods for producing and using the same and compositions comprising the same | Chemistry; Metallurgy | 13 | Expired |
| US6635257B1 | Particles of HCV envelope proteins: use for vaccination | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7387879B2 | Diagnosis of tauopathies | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7422848B2 | Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6974864B2 | Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents | Chemistry; Metallurgy | 10 | Expired |
| US6025132A | Probes targeted to rRNA spacer regions, methods and kits for using said probes, for the detection of respiratory tract pathogens | Chemistry; Metallurgy | 10 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.